Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Arthritis, Rheumatoid | 9 | 2021 | 2043 | 1.09 | Why? |
| Antirheumatic Agents | 8 | 2021 | 3023 | 0.91 | Why? |
| Rheumatology | 3 | 2021 | 1213 | 0.62 | Why? |
| Rheumatic Diseases | 5 | 2021 | 2675 | 0.56 | Why? |
| Drug Substitution | 1 | 2017 | 385 | 0.54 | Why? |
| Biological Products | 3 | 2020 | 2331 | 0.33 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.27 | Why? |
| Registries | 10 | 2021 | 12327 | 0.27 | Why? |
| Glucocorticoids | 3 | 2021 | 4431 | 0.21 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.16 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.15 | Why? |
| Isoxazoles | 1 | 2014 | 68 | 0.14 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.14 | Why? |
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 94 | 0.14 | Why? |
| Musculoskeletal Diseases | 1 | 2021 | 646 | 0.12 | Why? |
| Lymphoma | 1 | 2017 | 522 | 0.12 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.11 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
| Germany | 4 | 2021 | 9196 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.10 | Why? |
| Methotrexate | 1 | 2014 | 471 | 0.10 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.10 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.09 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.09 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.07 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.07 | Why? |
| Arthritis, Psoriatic | 2 | 2020 | 625 | 0.07 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.06 | Why? |
| Aged | 8 | 2021 | 215776 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.06 | Why? |
| Polymyalgia Rheumatica | 1 | 2020 | 64 | 0.05 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| Female | 9 | 2021 | 380317 | 0.05 | Why? |
| Spondylarthropathies | 1 | 2020 | 163 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Lupus Erythematosus, Systemic | 2 | 2020 | 1380 | 0.05 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.05 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2020 | 161 | 0.04 | Why? |
| Spondylitis, Ankylosing | 1 | 2020 | 231 | 0.04 | Why? |
| Lymphoma, T-Cell | 1 | 2017 | 70 | 0.04 | Why? |
| Humans | 12 | 2021 | 930598 | 0.04 | Why? |
| Lymphoma, B-Cell | 1 | 2017 | 166 | 0.04 | Why? |
| Prednisone | 1 | 2020 | 652 | 0.04 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Janus Kinase Inhibitors | 1 | 2020 | 682 | 0.03 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Lymphoma, Non-Hodgkin | 1 | 2017 | 403 | 0.03 | Why? |
| Scleroderma, Systemic | 1 | 2020 | 583 | 0.03 | Why? |
| Vasculitis | 1 | 2020 | 691 | 0.03 | Why? |
| Europe | 2 | 2021 | 12702 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Rituximab | 1 | 2014 | 1096 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2014 | 3776 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 2014 | 7268 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2014 | 17020 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |